These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22723845)

  • 1. Human SOD2 modification by dopamine quinones affects enzymatic activity by promoting its aggregation: possible implications for Parkinson's disease.
    Belluzzi E; Bisaglia M; Lazzarini E; Tabares LC; Beltramini M; Bubacco L
    PLoS One; 2012; 7(6):e38026. PubMed ID: 22723845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Therapeutic Implications of Tea Polyphenols Against Dopamine (DA) Neuron Degeneration in Parkinson's Disease (PD).
    Zhou ZD; Xie SP; Saw WT; Ho PGH; Wang H; Lei Z; Yi Z; Tan EK
    Cells; 2019 Aug; 8(8):. PubMed ID: 31426448
    [No Abstract]   [Full Text] [Related]  

  • 3. Superoxide Dismutases SOD1 and SOD2 Rescue the Toxic Effect of Dopamine-Derived Products in Human SH-SY5Y Neuroblastoma Cells.
    Biosa A; De Lazzari F; Masato A; Filograna R; Plotegher N; Beltramini M; Bubacco L; Bisaglia M
    Neurotox Res; 2019 Nov; 36(4):746-755. PubMed ID: 31228093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switch of Mitochondrial Superoxide Dismutase into a Prooxidant Peroxidase in Manganese-Deficient Cells and Mice.
    Ganini D; Santos JH; Bonini MG; Mason RP
    Cell Chem Biol; 2018 Apr; 25(4):413-425.e6. PubMed ID: 29398562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of rat brain mitochondrial electron transport chain activity by dopamine oxidation products during extended in vitro incubation: implications for Parkinson's disease.
    Khan FH; Sen T; Maiti AK; Jana S; Chatterjee U; Chakrabarti S
    Biochim Biophys Acta; 2005 Jun; 1741(1-2):65-74. PubMed ID: 15925494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of dopamine-derived quinones reactivity toward NADH and glutathione: implications for mitochondrial dysfunction in Parkinson disease.
    Bisaglia M; Soriano ME; Arduini I; Mammi S; Bubacco L
    Biochim Biophys Acta; 2010 Sep; 1802(9):699-706. PubMed ID: 20600874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.
    Zuo L; Motherwell MS
    Gene; 2013 Dec; 532(1):18-23. PubMed ID: 23954870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine quinone modifies and decreases the abundance of the mitochondrial selenoprotein glutathione peroxidase 4.
    Hauser DN; Dukes AA; Mortimer AD; Hastings TG
    Free Radic Biol Med; 2013 Dec; 65():419-427. PubMed ID: 23816523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
    Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
    PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-sensing microRNA-21 disrupts ROS homeostasis and impairs antioxidant responses in cellular glucose variability.
    La Sala L; Mrakic-Sposta S; Micheloni S; Prattichizzo F; Ceriello A
    Cardiovasc Diabetol; 2018 Jul; 17(1):105. PubMed ID: 30037352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease.
    Hastings TG
    J Bioenerg Biomembr; 2009 Dec; 41(6):469-72. PubMed ID: 19967436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?
    Bisaglia M; Filograna R; Beltramini M; Bubacco L
    Ageing Res Rev; 2014 Jan; 13():107-14. PubMed ID: 24389159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS.
    Chen Y; Zhang J; Lin Y; Lei Q; Guan KL; Zhao S; Xiong Y
    EMBO Rep; 2011 Jun; 12(6):534-41. PubMed ID: 21566644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal brain oxidative and nitrative stress levels are finely regulated by the interplay between superoxide dismutase 2 and p53.
    Barone E; Cenini G; Di Domenico F; Noel T; Wang C; Perluigi M; St Clair DK; Butterfield DA
    J Neurosci Res; 2015 Nov; 93(11):1728-39. PubMed ID: 26251011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Mitochondrial Oxidative Damage Improves Reendothelialization Capacity of Endothelial Progenitor Cells via SIRT3 (Sirtuin 3)-Enhanced SOD2 (Superoxide Dismutase 2) Deacetylation in Hypertension.
    He J; Liu X; Su C; Wu F; Sun J; Zhang J; Yang X; Zhang C; Zhou Z; Zhang X; Lin X; Tao J
    Arterioscler Thromb Vasc Biol; 2019 Aug; 39(8):1682-1698. PubMed ID: 31189433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mechanisms for superoxide-scavenging activity of human manganese superoxide dismutase determined by the K68 key acetylation site.
    Lu J; Cheng K; Zhang B; Xu H; Cao Y; Guo F; Feng X; Xia Q
    Free Radic Biol Med; 2015 Aug; 85():114-26. PubMed ID: 25908444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson's disease.
    Liu L; Peritore C; Ginsberg J; Shih J; Arun S; Donmez G
    Behav Brain Res; 2015 Mar; 281():215-21. PubMed ID: 25541039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis.
    Jiang H; Ren Y; Zhao J; Feng J
    Hum Mol Genet; 2004 Aug; 13(16):1745-54. PubMed ID: 15198987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of proteasomal inhibition and apoptosis induced in N27 mesencephalic cells by dopamine and MG132.
    Zafar KS; Inayat-Hussain SH; Ross D
    J Neurochem; 2007 Aug; 102(3):913-21. PubMed ID: 17504267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.